An experimental medication for critically ill COVID-19 patients appears to work so well that the drug’s maker announced Monday it has stopped its clinical trial early and will apply for emergency use authorization. The medication, sabizabulin, halved the death rate in COVID-19 patients who were receiving supplemental oxygen and were at high risk of serious…  read on >  read on >

A single dose of human papillomavirus (HPV) vaccine provides as much protection against cervical cancer as the standard three-dose regimen, a new study finds. “These findings are a game-changer that may substantially reduce the incidence of HPV-attributable cervical cancer, and positions single-dose HPV vaccination as a high-value and high-impact public health intervention that is within…  read on >  read on >

If you suffer from headaches, you have plenty of company. Headaches afflict half of the world’s population, and women are more likely to get them than men, a new paper says. “We found that the prevalence of headache disorders remains high worldwide and the burden of different types may impact many. We should endeavor to…  read on >  read on >

MONDAY, April 11, 2022 (American Heart Association News) — Anyone who has been on the receiving end of a dog’s love and devotion knows these furry friends are nothing if not good for our hearts. There’s plenty of research to show that’s more than a warm, fuzzy feeling. Studies show dog ownership benefits heart health…  read on >  read on >

Older children and teens are the most vulnerable to severe cases of a rare inflammatory disorder that can occur in youngsters who’ve had COVID-19, a new study finds. It included 232 children aged 18 and younger who were admitted to 15 hospitals in Canada, Costa Rica and Iran with suspected multi-system inflammatory syndrome (MIS-C) between…  read on >  read on >